Calmare Therapeutics, Inc. engages in the research, development, and commercialization of chronic, neuropathic pain and wound affliction devices. It offers licensing and technology sourcing. The company was founded in 1968 and is headquartered in Fairfield, CT.
Company profile
Ticker
CTTC
Exchange
Website
CEO
Conrad F. Mir
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
Competitive Technologies Inc
SEC CIK
Corporate docs
IRS number
362664428
CTTC stock data
Latest filings (excl ownership)
REVOKED
Registration or securities revoked
17 Jul 23
8-K
Calmare Therapeutics Awarded $2.5 Million, Five-year
9 Jun 20
8-K
Other Events
5 Nov 19
8-K
Departure of Directors or Certain Officers
19 Jul 19
8-K
Departure of Directors or Certain Officers
12 Jun 19
8-K
Other Events
10 Jun 19
8-K
Other Events
3 Jun 19
8-K
Calmare Therapeutics Receives Two Favorable Rulings
25 Mar 19
8-K
Other Events
18 Mar 19
8-K/A
Submission of Matters to a Vote of Security Holders
2 Jul 18
Latest ownership filings
SC 13G/A
CALMARE THERAPEUTICS Inc
11 Feb 20
SC 13G/A
CALMARE THERAPEUTICS Inc
14 Feb 19
4
Thomas Philip Richtarich
6 Mar 18
4
Conrad F Mir
6 Mar 18
4
Peter F Brennan
6 Mar 18
SC 13G/A
CALMARE THERAPEUTICS Inc
14 Feb 18
SC 13G
CALMARE THERAPEUTICS Inc
13 Feb 18
SC 13D/A
CALMARE THERAPEUTICS Inc
21 Sep 17
SC 13D
CALMARE THERAPEUTICS Inc
30 Jun 17
SC 13G
CALMARE THERAPEUTICS Inc
14 Feb 17
Institutional ownership, Q3 2019
13F holders | Current |
---|---|
Total holders | 0 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 0.00 |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|